SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-145243
Filing Date
2021-04-30
Accepted
2021-04-30 16:31:15
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d169773d10ka.htm   iXBRL 10-K/A 674487
2 EX-31.3 d169773dex313.htm EX-31.3 3185
3 EX-31.4 d169773dex314.htm EX-31.4 3170
  Complete submission text file 0001193125-21-145243.txt   921909

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cprx-20201231.xsd EX-101.SCH 4992
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20201231_cal.xml EX-101.CAL 685
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20201231_def.xml EX-101.DEF 1690
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20201231_lab.xml EX-101.LAB 20315
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20201231_pre.xml EX-101.PRE 15884
9 EXTRACTED XBRL INSTANCE DOCUMENT d169773d10ka_htm.xml XML 7586
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33057 | Film No.: 21878662
SIC: 2834 Pharmaceutical Preparations